A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 46, Issue 4, 2005, Pages 553-560

  Molica, Stefano ^a   Mauro, Francesca R ^d   Callea, Vincenzo ^b   Gentile, Massimo ^b   Giannarelli, Diana ^b   Lopez, Manuela ^b   Lauria, Francesco ^b   Rotoli, Bruno ^b   Montanaro, Marco ^b   Cortelezzi, Agostino ^b   Liso, Vincenzo ^b   Mandelli, Franco ^b   Foa, Robin ^d   Leoni, ^b   Montanari, ^b   Giustolisi, ^b   Stagno, ^b   Molica, ^b   D'Arco, ^b   Chiurazzi, ^b   Mariani, ^b   Iannitto, ^b   Mirto, ^b   Felici, ^b   Ascari, ^b   Invernizzi, ^b   Nobile, ^b   Leone, ^c   Laurenti, ^c   Longinotti, ^b   Dore, ^b   Lazzarino, ^b   Pagnucco, ^b   Del Favero, ^b   Liberati, ^b   Gallamini, ^b   Zanella, ^b   Barcellini, ^b   Maiolo, ^b   Petrini, ^b   Galimberti, ^b   Marotta, ^b   Niscola, ^b   Torelli, ^b   Morselli, ^b   Andriani, ^e   Zamboni, ^b   Miraglia, ^b   more..

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b Roma Univ Cattolica ^*

^c CATHOLIC UNIVERSITY   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e San Giacomo Hospital   (Italy)

Author keywords

Disease progression; Early CLL; Gender

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; FEMALE; GENE DELETION; HUMAN; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUTATION RATE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE;

EID: 20244381529     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400029965     Document Type: Article

References (31)

1. Rozman C, Montserrat E. Chronic lymphocytic leukaemia. N Engl J Med 1995;333:1052-1057.
2. Molica S. Prognostic factors in chronic lymphocytic leukaemia. In: Cheson BD, editor. Chronic lymphocytic leukemias. 2nd ed. New York: Marcel Dekker; 2001. p 231-260.
3. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
4. Binet JL, Lepoprier M, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855-864.
5. Montserrat E, Vinolas N, Reverter JC, Rozman C. Natural history of chronic lymphocytic leukaemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988;30:359-361.
6. French Cooperative Group on Chronic Lymphocytic Leukemia. Natural history of stage A chronic lymphocytic leukaemia untreated patients. Br J Haematol 1990;76:45-57.
7. Keating M, Lerner S, Kantarjian H, Freireich E, O'Brien S. The serum β2-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia (CLL). Blood 1995;86:606a.
8. Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, non-smoldering chronic lymphocytic leukemia. Blood 1999;93: 1732-1737.
9. Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996;88:4259-4264.
10. Molica S, Levato D, Cascavilla N, Levato L, Musto P. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β2-microglobulin in B-cell chronic lymphocytic leukemia. Eur J Haematol 1999;62:117-122.
11. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
12. Damle RN, Wasil T, Fais F, Ghiotti F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
13. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-1775.
14. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, Dohner H, Stilgenbauer S. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-1416.
15. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916.
16. Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biology insights into clinical practice for patients with CLL. Blood 2004;103:1202-1210.
17. Molica S. Progression and survival studies in early chronic lymphocytic leukemia. Blood 1991;78:895-899.
18. Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporrier M, Jaubert J, Lepeu G, Dreyfus B et al. Cholorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 1998;338:1506-1514.
19. Catovsky D, Halsey J, Richards S et al. Sex as a prognostic factor in CLL. An analysis from MRC trials. IX IWCLL, San Diego 22 - 24 March 2002:32a.
20. Dighiero G. Is chronic lymphocytic leukemia one disease? Haematologica 2002;87 (Suppl. II):31-33.
21. CLL Trialists' Collaborative Group. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of randomized trials. J Natl Cancer Inst 1999;91:861-868.
22. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, Corcoran MM, Chapman RM, Thomas PW, Copplestone JA et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177-1184.
23. Guarini A, Gaidano G, Mauro FR, Capello D, Mancini F, De Propis MS, Mansini M, Gentile M, Breccia M, Cuneo A et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003;102:1035-1041.
24. Magnac C, Porcher R, Davi F, Nataf J, Payelle-Brogard B, Tang RP, Oppezzo P, Levy V, Dighiero G, Ajchenbaum-Cymbalista F. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia 2003;17:133-137.
25. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98:181-186.
26. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944-4951.
27. Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002;99:1023-1029.
28. Vasconcelos Y, Davi F, Levy V, Oppezzo P, Magnac C, Michel A, Yamamoto M, Pritsch O, Merle-Beral H, Maloum K et al. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J Clin Oncol 2003;21:3928-3932.
29. Catovsky D, Matutes E, Morilla A, Burford A, Brito-Babapulle V, Del Giudice I, Orchard J, Oscier DG, Halsey J, Richards S. Gender as a prognostic factor in CLL. Biological pointers to the improved outcome of women. Blood 2004;104 (Suppl. 1):274a.
30. Hamblin TJ, Orchard JA, Davies ZA, Ibbotson RE, Gardiner AC, Copplestone A, Oscier DG. In chronic lymphocytic leukemia females survive for longer than males even in patients with unmutated immunoglobulin genes. Blood 2004;104 (Suppl. 1):9a.
31. Multiple Myeloma 9th International Workshop, May 23 - 27, 2003, Salamanca, Spain. Hematol J 2003;4 (Suppl. 1):S282.